RUBIDOMYCIN: A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES.
D000818:Animals; D000900:Anti-Bacterial Agents; D002286:Carcinoma, Ehrlich Tumor; D003630:Daunorubicin; D007938:Leukemia; D007942:Leukemia, Experimental; D008175:Lung Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D015674:Mammary Neoplasms, Animal; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D010336:Pathology; D012106:Research; D012510:Sarcoma 180; D012513:Sarcoma, Experimental; D014116:Toxicology
D000900:Anti-Bacterial Agents; D003630:Daunorubicin
ANTIBIOTICS; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; SARCOMA 180, CROCKER; SARCOMA, EXPERIMENTAL; SARCOMA, RETICULUM CELL; TOXICOLOGIC REPORT